Study for metabolic syndrome caused by atypical antipsychotics with aerobic exercise intervention

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026154

Enrollment

Unknown

Registered

2019-09-24

Start date

2009-12-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome caused by atypical antipsychotics

Interventions

Group 2:aerobic exercise

Group 1:Low lipids foods

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 16 to 60 years old; 2. meet the diagnostic criteria for DSM-IV or ICD-10 schizophrenia; 3. schizophrenia patients who have started to use or switch to (not including dose adjustment) risperidone, olanzapine, clozapine orally.

Exclusion criteria

Exclusion criteria: 1. Consolidation of patients with physical diseases such as diabetes, essential hypertension, cardiovascular and cerebrovascular diseases; 2. Refractory patients need to be treated with antipsychotic drugs; 3. Accompanied by serious suicidal ideation or previous suicidal behavior; 4. participating in another intervention study at the same time.

Design outcomes

Primary

Measure	Time frame
weight;BMI;Blood glucose;Triglycerides;systolic blood pressure;Diastolic blood pressure;	—

Countries

China

Contacts

Public ContactWang Zhiren

Beijing Huilongguan Hospital

zhiren75@163.com+86 18910035617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026